Description
In the quest to develop better antipsychotic drugs for the treatment of schizophrenia, new compounds are currently being explored which promise fewer side effects and improved clinical outcome. This volume focuses on basic and clinical aspects of schizophrenia. It brings together leading researchers in the field to discuss the pharmacology and therapeutic effectiveness of neuroleptics developed to date and to consider future strategies for the discovery of new antipsychotic agents. The contributions report the results of clinical, neurochemical, neuroendocrinological and molecular studies on dopamine receptors which help to provide a rational basis for the definition of psychotic disorders and the development of new drug therapies.
